What Is GeneSight Genetic Testing and How Can It Help Your Treatment?
If you have tried multiple antidepressants and none of them have worked the way you hoped, there is a question worth asking before you try another one: is the problem the medication, or is the problem that the medication was never a good match for your biology in the first place? GeneSight genetic testing exists to answer that question. It is a simple cheek swab that analyzes your DNA and tells your psychiatrist which medications are likely to work well for you, which ones may work poorly, and which ones carry an elevated risk of side effects based on your specific genetic profile. It does not replace clinical judgment. It informs it, with data that was not available to psychiatrists a generation ago. At NeuPath Mind Wellness, GeneSight testing is available across all three of our South Florida locations and is one of the tools we use to build genuinely personalized treatment plans for patients who have spent too long cycling through medications that were never right for them. The Problem GeneSight Solves The standard approach to prescribing antidepressants has always involved a significant degree of guesswork. A psychiatrist evaluates your symptoms, considers your history, and selects a medication based on clinical guidelines and experience. If it does not work, or if the side effects are intolerable, you try another one. And another. And another. This trial-and-error process is not a failure of psychiatry. It reflects a genuine gap in the information available. Until recently there was no reliable way to know in advance how a specific patient’s body would process a specific medication. The same dose of the same drug can produce vastly different effects in two different people, and the reason for that difference is largely genetic. Approximately 40 percent of patients with depression do not achieve remission with their first antidepressant. Many cycle through multiple medications over months or years before finding something that works, if they find it at all. Each failed trial is not just a clinical setback. It is months of a patient’s life spent feeling worse than necessary, often with side effects layered on top of the underlying illness. GeneSight closes that information gap. How GeneSight Works GeneSight is a pharmacogenomic test, meaning it analyzes the relationship between your genes and how your body responds to medications. The test is developed and processed by Myriad Genetics, one of the leading pharmacogenomics laboratories in the United States. The process at NeuPath is simple: Step 1: The swab. A clinician collects a DNA sample using a simple cheek swab. The process takes less than a minute and is completely painless. Step 2: Laboratory analysis. The sample is sent to Myriad’s laboratory where your DNA is analyzed across a panel of genes relevant to psychiatric medication metabolism and response. Step 3: The report. Within a few days your psychiatrist receives a detailed GeneSight report that categorizes each medication in the psychiatric formulary into one of three groups based on your genetic profile. Step 4: Clinical integration. Your psychiatrist reviews the results with you and uses the findings to inform your treatment plan, whether that means adjusting your current medication, switching to a better-matched alternative, or confirming that your current approach is genetically sound. What the GeneSight Report Shows The GeneSight report organizes medications into three color-coded categories: Use as directed (green). Medications in this category are predicted to be processed normally by your body based on your genetic profile. They carry no elevated genetic risk and are reasonable options from a pharmacogenomic standpoint. Use with caution (yellow). Medications in this category may be less effective or may require dose adjustments due to how your genes affect their metabolism. Your psychiatrist may still prescribe them but will do so with the genetic data in mind. Use with increased caution and more frequent monitoring (red). Medications in this category carry a higher genetic risk of reduced efficacy, adverse reactions, or significant metabolic interactions. This does not mean they are never appropriate, but the data suggests they warrant careful consideration and close monitoring if prescribed. The report covers antidepressants, antipsychotics, anxiolytics, mood stabilizers, and other psychiatric medications, giving your psychiatrist a comprehensive genetic map of the entire psychiatric formulary as it applies to your specific biology. What Genes Does GeneSight Test? The GeneSight panel focuses primarily on two categories of genes: Pharmacokinetic genes govern how your body processes and metabolizes medications. The most clinically significant are the cytochrome P450 enzymes, particularly CYP2D6, CYP2C19, and CYP2C9. These enzymes are responsible for breaking down a large proportion of psychiatric medications in the liver. Genetic variants in these enzymes can make you a poor metabolizer, meaning a standard dose builds up to toxic levels in your system, or an ultra-rapid metabolizer, meaning your body clears the drug so quickly it never reaches therapeutic concentration. Either extreme explains why some patients feel terrible on medications that work well for others, or why a medication seems to stop working after a period of effectiveness. Pharmacodynamic genes influence how your brain responds to a medication once it has been absorbed. These include genes like SLC6A4, which affects serotonin transport and influences how patients respond to SSRIs, and MTHFR, which affects folate metabolism and has been associated with antidepressant response and treatment resistance. Understanding both dimensions, how your body processes the drug and how your brain responds to it, gives your psychiatrist a significantly more complete picture than symptom history alone. What GeneSight Can and Cannot Tell You GeneSight is a powerful tool but it is important to understand what it does and does not do. What it can tell you: What it cannot tell you: At NeuPath, GeneSight results are always interpreted by a psychiatrist within the full context of your clinical picture. The report is a data input, not a prescription. Who Benefits Most From GeneSight Testing? GeneSight is valuable for a wide range of patients, but it tends to produce the most meaningful clinical impact for those in the following situations: Patients
